Trial Details
COMPLETEDBasic Information
| Clinical ID | c4424 |
|---|---|
| Identifier | NCT00552058 |
| Trial Title | Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease |
| Interventions | BIOLOGICAL: certolizumab pegol (CDP870, CZP)|OTHER: Placebo |
Participant Information
| Sponsor | UCB Pharma |
|---|---|
| City | Pell City |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2008-03 |
|---|---|
| Primary Completion Date | 2009-10 |
| Completion Date | 2009-11 |